rs1760944
Orientation | minus |
Stabilized | minus |
Make rs1760944(A;A) |
Make rs1760944(A;C) |
Make rs1760944(C;C) |
Reference | GRCh38 38.1/141 |
Chromosome | 14 |
Position | 20454990 |
Gene | APEX1, OSGEP |
is a | snp |
is | mentioned by |
dbSNP | rs1760944 |
dbSNP (classic) | rs1760944 |
ClinGen | rs1760944 |
ebi | rs1760944 |
HLI | rs1760944 |
Exac | rs1760944 |
Gnomad | rs1760944 |
Varsome | rs1760944 |
LitVar | rs1760944 |
Map | rs1760944 |
PheGenI | rs1760944 |
Biobank | rs1760944 |
1000 genomes | rs1760944 |
hgdp | rs1760944 |
ensembl | rs1760944 |
geneview | rs1760944 |
scholar | rs1760944 |
rs1760944 | |
pharmgkb | rs1760944 |
gwascentral | rs1760944 |
openSNP | rs1760944 |
23andMe | rs1760944 |
SNPshot | rs1760944 |
SNPdbe | rs1760944 |
MSV3d | rs1760944 |
GWAS Ctlg | rs1760944 |
GMAF | 0.4073 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
[PMID 19631633] Haplotype-based case-control study between human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and cerebral infarction
[PMID 20010699] Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension
[PMID 21615620] A genetic variation in APE1 is associated with gastric cancer survival in a Chinese population
[PMID 19029194] Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans.
[PMID 19541747] Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
[PMID 21538578] Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population.
[PMID 23505922] Association of the polymorphism of APE1 gene with the risk of prostate cancer in Chinese Han population
[PMID 24257553] Apurinic/Apyrimidinic Endonuclease 1 Polymorphisms Are Associated With Ovarian Cancer Susceptibility in a Chinese Population
[PMID 31804681] Association between apurinic/apyrimidinic endonuclease 1 (APE1) rs1760944 T>G polymorphism and susceptibility of cancer: A meta-analysis involving 21,764 subjects.